A single intravitreal injection of UBX1325 (foselutoclax) was shown to be safe in patients with diabetic macular edema. The ...

PETALING JAYA, Malaysia, April 25, 2025 /PRNewswire/ -- In a landmark move to safeguard the vision of Malaysia's future ...

In a landmark move to safeguard the vision of Malaysia's future generation, VISTA Eye Specialist ('VISTA'), the nation's ...

The FDA has accepted for Priority Review the sBLA for aflibercept injection 8mg for the treatment of macular edema following RVO and for monthly dosing in approved indications.

Private equity (PE) firms have increased their ownership stake across health care sectors in the US. PE’s focus on short-term profitability may decrease the provision of unprofitable services, ...

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter ...

Discover surprising truths about blindness, from the spectrum of visual impairment to revolutionary treatments and adaptive ...

Authors of the study believe this potential will provide clinicians with valuable information about patient responses to treatment.

EYLEA ® (aflibercept) Injection 2 mg is a prescription medicine approved for the treatment of patients with Wet Age-Related Macular Degeneration (AMD), Macular Edema following Retinal Vein Occlusion ...

Two consultants from London’s Moorfields Eye Hospital restored vision for 24 young men in Bangladesh, following severe eye trauma sustained during pro-democracy protests.

The retinal surgery team, including Professor Nam Dong-heun, Lee Jun-woo, and Professor Kim Ye-won of Gachon University Gil ...